{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:38:01Z","timestamp":1793738281892,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20190623"],"award-info":[{"award-number":["20190623"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"VINNOVA","doi-asserted-by":"publisher","award":["2017-04689"],"award-info":[{"award-number":["2017-04689"]}],"id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2019-00487"],"award-info":[{"award-number":["2019-00487"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Government grant for clinical research Region Sk\u00e5ne Research Funds Donation Funds of Skane University Hospital Anna-Lisa and Sven Eric Lundgrens Foundation"},{"name":"Hans-Gabriel and Alice Trolle-Wachmeister\u2019s Foundation for Medical Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pre-clinical heart transplantation studies have shown that ex vivo non-ischemic heart preservation (NIHP) can be safely used for 24\u2009h. Here we perform a prospective, open-label, non-randomized phase II study comparing NIHP to\u00a0static cold preservation (SCS), the current standard for adult heart transplantation. All adult recipients on waiting lists for heart transplantation were included in the study, unless they met any exclusion criteria. The same standard acceptance criteria for donor hearts were used in both study arms. NIHP was scheduled in advance based on availability of device and trained team members. The primary endpoint was a composite of survival free of severe primary graft dysfunction, free of ECMO use within 7 days, and free of acute cellular rejection \u22652R within 180 days. Secondary endpoints were I\/R-tissue injury, immediate graft function, and adverse events. Of the 31 eligible patients, six were assigned to NIHP and 25 to SCS. The median preservation time was 223\u2009min (IQR, 202\u2013263) for NIHP and 194\u2009min (IQR, 164\u2013223) for SCS. Over the first six months, all of the patients assigned to NIHP achieved event-free survival, compared with 18 of those assigned to SCS (Kaplan-Meier estimate of event free survival 72.0% [95% CI 50.0\u201386.0%]). CK-MB assessed 6\u2009\u00b1\u20092\u2009h after ending perfusion was 76 (IQR, 50\u2013101) ng\/mL for NIHP compared with 138 (IQR, 72\u2013198)\u2009ng\/mL for SCS. Four deaths within six months after transplantation and three cardiac-related adverse events were reported in the SCS group compared with no deaths or cardiac-related adverse events in the NIHP group. This first-in-human study shows the feasibility and safety of NIHP for clinical use in heart transplantation. ClinicalTrial.gov, number NCT03150147<\/jats:p>","DOI":"10.1038\/s41467-020-16782-9","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T10:03:06Z","timestamp":1591956186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6860-6090","authenticated-orcid":false,"given":"Johan","family":"Nilsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Jernryd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-2013","authenticated-orcid":false,"given":"Guangqi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrius","family":"Paskevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Metzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trygve","family":"Sjo\u0308berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"16782_CR1","unstructured":"Domi\u0301nguez-Gil, B. & Matesanz, R. NEWSLETTER TRANSPLANT International figures on donation and transplantation 2017. EDQM 23,\u00a042\u201356\u00a0(2018)."},{"key":"16782_CR2","doi-asserted-by":"publisher","first-page":"e0118644","DOI":"10.1371\/journal.pone.0118644","volume":"10","author":"J Nilsson","year":"2015","unstructured":"Nilsson, J. et al. The International Heart Transplant Survival Algorithm (IHTSA): a new model to improve organ sharing and survival. PloS One 10, e0118644 (2015).","journal-title":"PloS One"},{"key":"16782_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/eurjhf\/hfs160","volume":"15","author":"G Dellgren","year":"2013","unstructured":"Dellgren, G. et al. Three decades of heart transplantation in Scandinavia: long-term follow-up. Eur. J. Heart Fail. 15, 308\u2013315 (2013).","journal-title":"Eur. J. Heart Fail."},{"key":"16782_CR4","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jtcvs.2006.09.019","volume":"133","author":"MJ Russo","year":"2007","unstructured":"Russo, M. J. et al. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. J. Thorac. Cardiovasc. Surg. 133, 554\u2013559 (2007).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"16782_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.healun.2014.02.027","volume":"33","author":"J Kobashigawa","year":"2014","unstructured":"Kobashigawa, J. et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J. Heart Lung Transpl. 33, 327\u2013340 (2014).","journal-title":"J. Heart Lung Transpl."},{"key":"16782_CR6","first-page":"163","volume":"6","author":"H Parlakpinar","year":"2017","unstructured":"Parlakpinar, H., Orum, M. H. & Ozhan, O. Myocardial necrosis markers in myocardial ischemia reperfusion (MI\/R) injury: a review. Med. Sci. 6, 163\u2013171 (2017).","journal-title":"Med. Sci."},{"key":"16782_CR7","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nm.2507","volume":"17","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig, H. K. & Eckle, T. Ischemia and reperfusion-from mechanism to translation. Nat. Med. 17, 1391\u20131401 (2011).","journal-title":"Nat. Med."},{"key":"16782_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/14017431.2016.1213876","volume":"50","author":"G Qin","year":"2016","unstructured":"Qin, G., Sjoberg, T., Liao, Q., Sun, X. & Steen, S. Intact endothelial and contractile function of coronary artery after 8 hours of heart preservation. Scand. Cardiovasc. J. 50, 362\u2013366 (2016).","journal-title":"Scand. Cardiovasc. J."},{"key":"16782_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/TP.0b013e31823cab44","volume":"93","author":"KJ Wood","year":"2012","unstructured":"Wood, K. J. & Goto, R. Mechanisms of rejection: current perspectives. Transplantation 93, 1\u201310 (2012).","journal-title":"Transplantation"},{"key":"16782_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jacc.2016.04.033","volume":"68","author":"S Chih","year":"2016","unstructured":"Chih, S., Chong, A. Y., Mielniczuk, L. M., Bhatt, D. L. & Beanlands, R. S. Allograft vasculopathy: the Achilles\u2019 heel of heart transplantation. J. Am. Coll. Cardiol. 68, 80\u201391 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"16782_CR11","first-page":"765","volume":"8","author":"Q Yang","year":"2016","unstructured":"Yang, Q., He, G. W., Underwood, M. J. & Yu, C. M. Cellular and molecular mechanisms of endothelial ischemia\/reperfusion injury: perspectives and implications for postischemic myocardial protection. Am. J. Transl. Res 8, 765\u2013777 (2016).","journal-title":"Am. J. Transl. Res"},{"key":"16782_CR12","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.healun.2018.07.022","volume":"37","author":"KK Khush","year":"2018","unstructured":"Khush, K. K. et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult heart transplantation report-2018; focus theme: multiorgan transplantation. J. Heart Lung Transplant. 37, 1155\u20131168 (2018).","journal-title":"J. Heart Lung Transplant."},{"key":"16782_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3109\/14017431.2016.1154598","volume":"50","author":"S Steen","year":"2016","unstructured":"Steen, S., Paskevicius, A., Liao, Q. & Sjoberg, T. Safe orthotopic transplantation of hearts harvested 24 hours after brain death and preserved for 24 hours. Scand. Cardiovasc. J. 50, 193\u2013200 (2016).","journal-title":"Scand. Cardiovasc. J."},{"key":"16782_CR14","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1016\/S0140-6736(15)60261-6","volume":"385","author":"A Ardehali","year":"2015","unstructured":"Ardehali, A. et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet 385, 2577\u20132584 (2015).","journal-title":"Lancet"},{"key":"16782_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/14017431.2019.1684553","volume":"54","author":"G Qin","year":"2020","unstructured":"Qin, G. et al. Intact coronary and myocardial functions after 24 hours of non-ischemic heart preservation. Scand. Cardiovasc. J. 54, 59\u201365 (2020).","journal-title":"Scand. Cardiovasc. J."},{"key":"16782_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-018-0765-z","volume":"564","author":"M Langin","year":"2018","unstructured":"Langin, M. et al. Consistent success in life-supporting porcine cardiac xenotransplantation. Nature 564, 430\u2013433 (2018).","journal-title":"Nature"},{"key":"16782_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cardfail.2015.08.339","volume":"22","author":"MA Schechter","year":"2016","unstructured":"Schechter, M. A. et al. Elevated cardiac troponin I in preservation solution is associated with primary graft dysfunction. J. Card. Fail. 22, 158\u2013162 (2016).","journal-title":"J. Card. Fail."},{"key":"16782_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/TP.0b013e3181e6f1eb","volume":"90","author":"MJ Russo","year":"2010","unstructured":"Russo, M. J. et al. Factors associated with primary graft failure after heart transplantation. Transplantation 90, 444\u2013450 (2010).","journal-title":"Transplantation"},{"key":"16782_CR19","first-page":"316","volume":"96","author":"H Pichon","year":"1997","unstructured":"Pichon, H. et al. Crystalloid versus cold blood cardioplegia and cardiac troponin I release. Circulation 96, 316\u2013320 (1997).","journal-title":"Circulation"},{"key":"16782_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.healun.2007.10.006","volume":"27","author":"DH Rosenbaum","year":"2008","unstructured":"Rosenbaum, D. H. et al. Perfusion preservation versus static preservation for cardiac transplantation: effects on myocardial function and metabolism. J. Heart Lung Transplant. 27, 93\u201399 (2008).","journal-title":"J. Heart Lung Transplant."},{"key":"16782_CR21","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.athoracsur.2013.03.014","volume":"95","author":"Y Yang","year":"2013","unstructured":"Yang, Y. et al. Keeping donor hearts in completely beating status with normothermic blood perfusion for transplants. Ann. Thorac. Surg. 95, 2028\u20132034 (2013).","journal-title":"Ann. Thorac. Surg."},{"key":"16782_CR22","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.athoracsur.2004.02.143","volume":"78","author":"RS Poston","year":"2004","unstructured":"Poston, R. S. et al. Optimizing donor heart outcome after prolonged storage with endothelial function analysis and continuous perfusion. Ann. Thorac. Surg. 78, 1362\u20131370 (2004).","journal-title":"Ann. Thorac. Surg."},{"key":"16782_CR23","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/tri.12361","volume":"28","author":"S Messer","year":"2015","unstructured":"Messer, S., Ardehali, A. & Tsui, S. Normothermic donor heart perfusion: current clinical experience and the future. Transpl. Int. 28, 634\u2013642 (2015).","journal-title":"Transpl. Int."},{"key":"16782_CR24","doi-asserted-by":"publisher","first-page":"S910","DOI":"10.21037\/jtd.2018.02.85","volume":"10","author":"D Van Raemdonck","year":"2018","unstructured":"Van Raemdonck, D., Rega, F., Rex, S. & Neyrinck, A. Machine perfusion of thoracic organs. J. Thorac. Dis. 10, S910\u2013S923 (2018).","journal-title":"J. Thorac. Dis."},{"key":"16782_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.21037\/acs.2017.12.02","volume":"7","author":"K Koomalsingh","year":"2018","unstructured":"Koomalsingh, K. & Kobashigawa, J. A. The future of cardiac transplantation. Ann. Cardiothorac. Surg. 7, 135\u2013142 (2018).","journal-title":"Ann. Cardiothorac. Surg."},{"key":"16782_CR26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nbt.4157","volume":"36","author":"M Senior","year":"2018","unstructured":"Senior, M. Beating the organ clock. Nat. Biotechnol. 36, 488\u2013492 (2018).","journal-title":"Nat. Biotechnol."},{"key":"16782_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","volume":"35","author":"MR Mehra","year":"2016","unstructured":"Mehra, M. R. et al. The 2016 International Society for heart lung transplantation listing criteria for heart transplantation: a 10-year update. J. Heart Lung Transplant. 35, 1\u201323 (2016).","journal-title":"J. Heart Lung Transplant."},{"key":"16782_CR28","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","volume":"24","author":"S Stewart","year":"2005","unstructured":"Stewart, S. et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J. Heart Lung Transplant. 24, 1710\u20131720 (2005).","journal-title":"J. Heart Lung Transplant."},{"key":"16782_CR29","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran, R. et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123, 2736\u20132747 (2011).","journal-title":"Circulation"},{"key":"16782_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1053\/j.ajkd.2013.02.350","volume":"61","author":"M James","year":"2013","unstructured":"James, M. et al. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am. J. Kidney Dis. 61, 673\u2013685 (2013).","journal-title":"Am. J. Kidney Dis."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16782-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16782-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16782-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T23:16:07Z","timestamp":1670282167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16782-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["16782"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-16782-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]},"assertion":[{"value":"2 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The device was patented by S.S. The patent is now owned by XVIVO Perfusion AB (G\u00f6teborg, Sweden). XVIVO Perfusion AB had no involvement in the study. The authors of this manuscript have no other competing interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2976"}}